Área salud
Vol. 2. Issue. 4. (October – December 2022)
Área salud
HaNDL syndrome after COVID-19
Área salud
Physical fatigue and perceived fatigability in adolescents and adults with spinal muscular atrophy: A pilot study
Introduction Fatigability is a frequent phenomenon in spinal muscular atrophy (SMA). However, there is a lack of scales designed for and validated in SMA patients to determine the frequency and impact on daily life of […]
Área salud
POEMS syndrome in Colombia: Clinical findings, therapeutic options and outcomes in a case series
Introduction POEMS syndrome is a paraneoplastic syndrome associated with a clonal plasma cell neoplasm, in general is a rare disease and its descriptions are based on series and case reports. Objective To describe the clinical […]
Área salud
First report of spastic ataxia of Charlevoix-Saguenay cases in Mexico. Novel SACS gene mutations identified
Introduction and objectives Spinocerebellar ataxia autosomal recessive (SCAR) represents a heterogeneous chronic and progressive neurological diseases group. They usually occur at an early age in a progressive manner. Diagnosis is complex due to phenotypic overlap. […]
Área salud
Clinical and epidemiological characterization of visually impaired patients due to neuro-ophthalmologic alterations
Background Several neurological pathologies affect visual functions (transitorily or permanently). However, the magnitude and epidemiological behavior of these as potential causes of low vision and blindness are unknown. This study aims to characterize patients clinically […]
Área salud
Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case series from 4 Colombian cities during the pandemic
SARS-CoV-2 infection has been associated with multiple neurological manifestations. One such manifestation, which has been described since the early stages of the COVID-19 pandemic and is relevant for current neurological practice, is Guillain-Barré syndrome (GBS). […]
Área salud
Involvement of the Endocannabinoid System in the pathophysiology and therapeutics of movement disorders
Introduction Control of movement is a complex process within the brain. Although some approaches have been already made in the employment of cannabinoid-related compounds for the treatment of pathologies such as Parkinson's Disease (PD), there […]